home / stock / evok / evok news


EVOK News and Press, Evoke Pharma Inc. From 09/03/20

Stock Information

Company Name: Evoke Pharma Inc.
Stock Symbol: EVOK
Market: NASDAQ
Website: evokepharma.com

Menu

EVOK EVOK Quote EVOK Short EVOK News EVOK Articles EVOK Message Board
Get EVOK Alerts

News, Short Squeeze, Breakout and More Instantly...

EVOK - Evoke Pharma inks distribution deal for Gimoti

Evoke Pharma (NASDAQ: EVOK ) has entered into a sales and distribution agreement with Eversana Life Science Services, as contemplated by the commercial services agreement dated January 2020. More news on: Evoke Pharma, Inc., Healthcare stocks news, Read more ...

EVOK - Evoke Pharma and EVERSANA Announce the Appointment of Christopher Quesenberry as Chief Commercial Officer for Gimoti(TM)

SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and EVERSANA™, a leading provider of global commercial services to the life science indus...

EVOK - Evoke Pharma EPS misses by $0.20

Evoke Pharma (NASDAQ: EVOK ) : Q2 GAAP EPS of -$0.28 misses by $0.20 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

EVOK - Evoke Pharma Reports Second Quarter 2020 Financial Results

SOLANA BEACH, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the second quarter ended June 30, 2020. “The recent FDA...

EVOK - Evoke Pharma Initiates Commercial Manufacturing of Gimoti(TM)

SOLANA BEACH, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has initiated the commercial manufacturing of Gimoti™ (metoclopramide) nasal...

EVOK - Evoke Pharma Extends Cash Runway to 2Q 2021

SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that as of June 30, 2020 it had cash and cash equivalents of approximately $8.0 million.&#x...

EVOK - NVTA, ATHX, BBGI and AFH among midday movers

Gainers: Sintx Technologies (NASDAQ: SINT )  +169% . More news on: Sintx Technologies, Inc., Evoke Pharma, Inc., Ideanomics, Inc., Stocks on the move, , Read more ...

EVOK - NIO, SPCE among premarket gainers

Evoke Pharma (NASDAQ: EVOK ) +85%  on FDA approval . More news on: Evoke Pharma, Inc., Theratechnologies Inc., Broadway Financial Corporation, Stocks on the move, , Read more ...

EVOK - Top Biotech Stocks Under $3 To Watch Before July 2020

Are These Biotech Stocks Poised For Breakouts This Week? Unless you have been under a rock lately, you know how volatile the markets are right now. For investors constantly looking for the next breakout, small-cap biotech stocks have been the focus this year. Now, perhaps you are new to th...

EVOK - Evoke Pharma +71% PM on FDA approval

Evoke Pharma (NASDAQ: EVOK ) shares continue to rise as FDA approved their Gimoti (metoclopramide) nasal spray on Friday. More news on: Evoke Pharma, Inc., Stocks on the move, Read more ...

Previous 10 Next 10